The latest report to surface regarding Invokana and other SGLT2 inhibitors in the same drug family has added yet another serious side effect to the growing list. The FDA has already launched an investigation into reports that have linked the medicines to ketoacidosis, which results when ketone levels create excessive acids in the blood. Now we can add pancreatitis to the list of side effects, and this one is serious as it is a rare and very deadly condition that results from the inflammation of the pancreas. This latest news will not bode well for the maker of Invokana, which is already the subject of numerous lawsuits.
The Current Side Effects Associated with Invokana
To understand the side effects associated with Invokana, you need to understand the mechanics of hyperglycemia (high blood sugar) and how the medication works to reduce blood sugar in type-2 diabetics. One of the ways in which glucose is eliminated from the body is through our urine and Invokana prevents the kidneys from reabsorbing excess glucose, thus passing it through the urine instead of back into the blood stream. Due to these mechanics, the following side effects are now suspected and linked to the medication.